1X10^6 PHA activated human PBMCs were surface stained with 5 ul CoraLite® Plus 750 Anti-Human ALCAM (CL750-65223, Clone:3A6). Cells were not fixed. Monocytes were gated.
1X10^6 HeLa cells were intracellularly stained with 5 ul CoraLite®750 Anti-Human LAMP1 (CL750-65051, Clone:H4A3). Cells were fixed with 4% PFA and permeabilized with Intracellular Staining Permeabilization Wash Buffer.
1X10^6 HeLa cells were intracellularly stained with 5 ul CoraLite®750 Anti-Human LAMP1 (CL750-65051, Clone:H4A3). Cells were fixed with 4% PFA and permeabilized with Intracellular Staining Permeabilization Wash Buffer.
1X10^6 human PBMCs were surface stained with 5 ul CoraLite® Plus 750 Anti-Human CD11a (CL750-65194, Clone:TS2/4) or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.
1X10^6 human PBMCs were surface stained with 5 ul CoraLite® Plus 750 Anti-Human CD11a (CL750-65194, Clone:TS2/4) or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.
1X10^6 human PBMCs were surface stained with 5 ul CoraLite® Plus 750 Anti-Human CD11b (CL750-65116, Clone: ICRF44). Cells were not fixed. Monocytes were gated.
1X10^6 human PBMCs were surface stained with 5 ul CoraLite® Plus 750 Anti-Human CD11c (CL750-65196, Clone:BU15). Cells were not fixed. Monocytes were gated.
1X10^6 human PBMCs were surface co-stained with PE Anti-Human CD45RO and 5 ul CoraLite® Plus 750 Anti-Human CD123 (CL750-65256, Clone:HI12H7), or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.
1X10^6 human whole blood granulocytes were surface stained with 5 ul CoraLite® Plus 750 Anti-Human CD13 (CL750-65186, Clone: WM15) or Mouse IgG1 Isotype Control. Cells were not fixed.
1X10^6 human whole blood granulocytes were surface stained with 5 ul CoraLite® Plus 750 Anti-Human CD13 (CL750-65186, Clone: WM15) or Mouse IgG1 Isotype Control. Cells were not fixed.